Related Experiment Video
Updated: Oct 8, 2025

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Hypoventilation and progressive encephalopathy in a neonate with MTHFR deficiency
Kiran Vemireddy1, Nalinikanta Panigrahy2, Lokesh Lingappa3
1Neonatology, Rainbow Children's Hospital, Hyderabad, Telangana, India.
Abstract:
Methylenetetrahydrofolate reductase (MTHFR) deficiency is a rare autosomal recessive inherited inborn error of metabolism, which presents with various severity depending on the level of residual enzyme activity. In neonates, it can present with recurrent hypoventilation episodes, persistent encephalopathy with or without microcephaly. MTHFR deficiency also results in hyperhomocysteinemia, homocystinuria and hypomethionemia. We report a male neonate with severe MTHFR deficiency presenting to us on third week of life with progressive encephalopathy, microcephaly, seizures, central hypoventilation. There was similar history in the previous sibling. The patient's blood lactate, ammonia, tandem mass spectrometry for amino acids and acyl carnitine were normal. He remained encephalopathic with progressive increase in need of respiratory support in spite of supportive treatment and metabolic cocktail consisting of riboflavin, pyridoxine, coenzyme Q and carnitine. This neonate had novel homozygous mutation, which results in MTHFR deficiency. In newborn with hypoventilation or recurrent apnoea with encephalopathy and microcephaly, MTHFR deficiency should be considered as a differential diagnosis. Mutation study helps in confirming diagnosis; however, extended newborn metabolic screening with homocysteine level could help in early diagnosis of these cases.
Insights
Methylenetetrahydrofolate reductase (MTHFR) deficiency, a rare metabolic disorder, can cause severe neurological issues in newborns. Early diagnosis via homocysteine screening is crucial for affected infants.
Area of Science:
- Biochemistry
- Genetics
- Neonatology
Background:
- Methylenetetrahydrofolate reductase (MTHFR) deficiency is an inherited metabolic disorder with variable clinical severity.
- It presents in neonates with symptoms like hypoventilation, encephalopathy, and microcephaly, alongside metabolic derangements such as hyperhomocysteinemia.
Observation:
- A male neonate with severe MTHFR deficiency presented with progressive encephalopathy, microcephaly, seizures, and central hypoventilation.
- Standard metabolic tests were normal, and the infant showed limited response to supportive care and a metabolic cocktail.
- A novel homozygous mutation was identified, confirming the diagnosis of MTHFR deficiency.
Findings:
- Severe MTHFR deficiency can manifest with critical neurological and respiratory symptoms in neonates.
- A novel mutation was identified in a patient with severe MTHFR deficiency and a history of similar symptoms in a sibling.
- Standard newborn screening may not detect all cases of MTHFR deficiency.
Implications:
- MTHFR deficiency should be considered in the differential diagnosis of newborns presenting with hypoventilation, apnea, encephalopathy, and microcephaly.
- Mutation analysis is key for confirming the diagnosis.
- Extended newborn screening including homocysteine levels could facilitate earlier detection of MTHFR deficiency.
Related Concept Videos
Inborn Errors of Metabolism
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-III
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Hyperpnea and Hyperventilation

